Armetheon Obtains $7,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb9eb9c0-d573-4036-8294-fc8ff02efbbc - Date
8/29/2014 - Company Name
Armetheon - Mailing Address
325 Sharon Park Drive Menlo Park, CA 94025 USA - Company Description
Armetheon, Inc., is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need in cardiovascular diseases. The company was founded by three successful biotech entrepreneurs and pharmaceutical executives with several years of drug R&D and company building experience. - Website
http://www.armetheon.com - Transaction Type
Venture Equity - Transaction Amount
$7,000,000 - Transaction Round
Series A - Proceeds Purposes
The funds will be used to keep to our NDA filing timeline in 2017 for Tecarfarin. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
